Idiosyncratic drug-induced agranulocytosis;Agranulocytoses médicamenteuses idiosyncrasiques

Revue de Medecine Interne

Volumn 27, Issue 3, 2006, Pages 209-214

  Andres E ^a   Maloisel, F ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Agranulocytosis; Drug; Fever; Hematopoietic growth factor; Iatrogenic effect; Neutropenia

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTITHYROID AGENT; HEMOPOIETIC GROWTH FACTOR; TICLOPIDINE;

AGRANULOCYTOSIS; FEVER; HUMAN; INFECTION; MORTALITY; NEUTROPENIA; NEUTROPHIL COUNT; PNEUMONIA; REVIEW; SEPSIS; SEPTIC SHOCK; SEPTICEMIA; SORE THROAT;

EID: 33644520937     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.06.008     Document Type: Short Survey

References (45)

1. E. Andr̀s, F. Maloisel, G. Kaltenbach, E. Noel, M. Alt le groupe d'́tude des agranulocytoses ḿdicamenteuses des Höpitaux universitaires de Strasbourg Agranulocytoses ḿdicamenteuses:: donńes actuelles Ann. Biol. Clin. 61 2003 121 124
2. E. Andr̀s, J.E. Kurtz, and F. Maloisel Non-chemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature Clin. Lab. Haematol. 24 2002 99 106
3. C. B́nichou, and P. Solal-Celigny Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting Nouv. Rev. Fr. Hematol. 33 1993 257 262
4. D.C. Dale, D. Guerry 4th, J.R. Wewerka, J.M. Bull, and M.J. Chusid Chronic neutropenia Medicine 58 1979 128 144 (Baltimore)
5. D.W. Kaufman, J.P. Kelly, M. Levy, and S. Shapiro The drug etiology of agranulocytosis and aplastic anaemia 1991 Oxford University Press Oxford 148 158
6. E. Andr̀s, F. Maloisel, C. Offner, F. Grunenberger, J.C. Weber, and N. Neyrolles Agranulocytoses ḿdicamenteuses:: exṕrience du CHRU de Strasbourg Sem. Hop. Paris 74 1998 1005 1010
7. B.L. Strom, J.L. Carson, R. Schinnar, E.S. Snyder, and M. Shaw Descriptive epidemiology of agranulocytosis Arch. Intern. Med. 152 1992 1475 1480
8. E. Andr̀s, and F. Maloisel Drug-associated agranulocytosis: experience at Strasbourg Teaching Hospital Arch. Intern. Med. 159 1999 2366 2367
9. J.E. Kurtz, E. Andr̀s, F. Maloisel, V. Kurtz-Illig, D. Heitz, and J. Sibilia Drug-induced agranulocytosis in elderly. A case series of 25 patients Age Aging 28 1999 325 326
10. E. Andr̀s, F. Maloisel, J.E. Kurtz, G. Kaltenbach, M. Alt, and J.C. Weber Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature Eur. J. Intern. Med. 13 2002 324 328
11. M.M. Van der Klauw, J.H. Wilson, and B.H. Stricker Drug-associated agranulocytosis: 20 years of reporting in the Netherlands (1974-1994) Am. J. Hematol. 57 1998 206 211
12. W.N. Patton, and S.B. Duffull Idiosyncratic drug-induced haematological abnormalities: incidence, pathogenosis, management and avoidance Drug Saf. 11 1994 445 462
13. A. Salama, B. Schütz, V. Kiefel, H. Breithaupt, and C. Mueller-Eckhardt Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies Br. J. Haematol. 72 1989 127 132
14. F.H. Claas Immune mechanisms leading to drug-induced blood dyscrasias Eur. J. Haematol. 60 suppl 1996 64 68
15. L.J. Lewitt Chlorpropamide-induced pure white cell aplasia Blood 69 1987 394 400
16. W.T. Gerson, D.G. Fine, S.P. Spielberg, and L.L. Sensenbrenner Anticonvulsivant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro Blood 61 1983 889 893
17. R. Weinshilboum Pharmacogenetics of methyl conjugation and thiopurine drug toxicity Prog. Clin. Biol. Res. 135 1983 167 181
18. N.S. Young Drug-related blood dyscrasias Eur. J. Haematol. 60 suppl 1996 6 8
19. N.S. Young, and B.F. Alter Agranulocytosis Aplastic anemia, acquired and inherited 1993 WB Saunders Co Philadelphia, Pa 227 264
20. e ed 1993 Lea & Febiger London 1864 1880
21. M.M. Van der Klauw, R. Goudsmit, M.R. Halie, M.B. van't Veer, R.M. Herings, and J.H. Wilson A population-based case-cohort study of drug-associated agranulocytosis Arch. Intern. Med. 159 1999 369 374
22. International agranulocytosis and aplastic anaemia Study Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs BMJ 297 1988 262 265
23. E. Andr̀s, and F. Maloisel Antibiotics induced agranulocytosis: a monocentric study of 21 cases Arch. Intern. Med. 161 2001 2619
24. S. Shapiro, S. Issaragrisil, D.W. Kaufman, T. Anderson, K. Chansung, and T. Thamprasit Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group Am. J. Trop. Med. Hyg. 60 1999 573 577
25. E. Andr̀s, F. Maloisel, J.E. Kurtz, S. Vinzio, J. Sibilia, and J.L. Schlienger Les facteurs de croissance h́matopoḯtique ont-ils une place dans le traitement des agranulocytoses ḿdicamenteuses:? Rev. Med. Interne 21 2000 580 585
26. J.J. Yunis, D. Corzo, M. Salazar, J. Lieberman, A. Howard, and E.J. Yunis HLA associations in clozapine-induced agranulocytosis Blood 86 1995 1177 1183
27. L. Hodinka, P. Geher, K. Meretey, E.K. Gyodi, G.G. Petranyi, and S. Boszoky Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies Int. Arch. Allergy Appl. Immunol. 65 1981 460 464
28. M. Dettling, I. Cascorbi, I. Roots, and B. Mueller-Oerlinghausen Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample Arch. Gen. Psychiatry 58 2001 93 94
29. S.M. Singhvi, K.L. Duchin, D.A. Willard, D.N. McKinstry, and B.H. Migdalof Renal handling of captopril: effect of probenecid Clin. Pharmacol. Ther. 32 1982 182 189
30. E. Andr̀s, E. Noel, J.E. Kurtz, N. Henoun Loukili, G. Kaltenbach, and F. Maloisel Life-threatening idiosyncratic drug-induced agranulocytosis in elderly patients Drugs Aging 21 2004 427 435
31. A. Julia, M. Olono, J. Bueno, E. Revilla, J. Rosselo, and J. Petit Drug-induced agranulocytosis: prognostic factors in a serie of 168 episodes Br. J. Hematol. 79 1991 366 372
32. J.F. Paitel, V. Stockemer, V. Dorvaux, F. Witz, A. Guerci, and P. Lederlin Agranulocytoses aiguës ḿdicamenteuses. Étude clinique ̀ propos de 30 patients et ́volution des ́tiologies sur deux d́cennies Rev. Med. Interne 16 1995 495 499
33. T. Vial, C. Pofilet, E. Pham, C. Payen, and J.C. Evreux Agranulocytoses aiguës ḿdicamenteuses:: exṕrience du Centre ŕgional de pharmacovigilance de Lyon sur sept ans Therapie 51 1996 508 515
34. W. Schultz Ueber eigenartige halserkrankungen Dtsch. Med. Wochenschr. 48 1922 1495 1496
35. E. Andr̀s, J.E. Kurtz, A.E. Perrin, P. Dufour, J.L. Schlienger, and F. Maloisel The use of haematopoietic growth factors in antithyroid-related drug-induced agranulocytosis: a report of 20 patients Q. J. Med. 94 2001 423 428
36. J. Tajiri, S. Noguchi, T. Murakami, and N. Murakami Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring Arch. Intern. Med. 150 1990 621 624
37. A. Sprikkelman, J.T.M. de Wolf, and E. Vellenga Application of haematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases Leukemia 8 1994 2031 2036
38. M.F. Beauchesne, and S.J. Shalansky Nonchemotherapy drug-induced agranulocytosis: a review of 118 patients treated with colony-stimulating factors Pharmacotherapy 19 1999 299 305
39. E. Andr̀s, J.E. Kurtz, C. Martin-Hunyadi, G. Kaltenbach, M. Alt, and J.C. Weber Non-chemotherapy drug-induced agranulocytosis in elderly patients: the effects of Granulocyte colony-stimulating factor Am. J. Med. 112 2002 460 464
40. F. Maloisel, E. Andr̀s, G. Kaltenbach, and E. Noel Prognostic factors of hematological recovery in nonchemotherapy drug-induced agranulocytosis Haematologica 88 2003 470 471
41. E. Andr̀s, E. Noel, and F. Maloisel Nonchemotherapy drug-induced agranulocytosis: interest of hematopoietic growth factors J. Intern. Med. 251 2002 533 534
42. E. Andr̀s, E. Noel, and F. Maloisel Long-term outcome of patients treated with hematopoietic growth factors for idiosyncratic drug-induced agranulocytosis Am. J. Med. 116 2004 354
43. S. Fukata, K. Kuma, and M. Sugawara Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study Thyroid 9 1999 29 31
44. F. Maloisel, E. Andr̀s, G. Kaltenbach, E. Noel, C. Martin-Hunyadi, and P. Dufour Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis. A study of 91 patients from a single center Presse Med. 33 2004 1164 1168
45. T. Vial, C. Gallant, G. Choquet-Katylevsky, and J. Descotes Treatment of drug-induced agranulocytosis with haematopoietic growth factors. A review of the clinical experience BioDrugs 11 1999 185 200